Longitudinal assessment of circulating YKL-40 levels should be considered in combination with the measurement of other biochemical markers such as ghrelin in AIS to better characterize their interplay during puberty and disease progression, including their validation in independent replication cohorts. Here, CHI3L1 is linked to androgen insensitivity syndrome.